Dr Reddys Laboratories (RDY) Cash from Operations Growth (5y) (2014 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.72 Bn | 39.07 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.34 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 494.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 399.34 Mn | 358.09 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.33 Mn | 178.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.85% |
| Sep 30, 2025 | 7.52% |
| Jun 30, 2025 | 3.56% |
| Sep 30, 2024 | -4.95% |
| Jun 30, 2024 | -6.32% |
| Mar 31, 2024 | 7.84% |
| Dec 31, 2023 | -24.08% |
| Sep 30, 2023 | 7.22% |
| Jun 30, 2023 | 30.79% |
| Mar 31, 2023 | 21.65% |
| Dec 31, 2022 | 19.51% |
| Sep 30, 2022 | 2.21% |
| Jun 30, 2022 | 36.92% |
| Mar 31, 2022 | 11.56% |
| Dec 31, 2021 | 20.23% |
| Sep 30, 2021 | -3.65% |
| Jun 30, 2021 | -21.23% |
| Mar 31, 2020 | -26.59% |
| Jun 30, 2019 | 13.09% |
| Mar 31, 2019 | -6.21% |